Essex Savings Bank’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12.4M | Sell |
10,367
-54
| -0.5% | -$55.2K | 2.69% | 4 |
|
|
2026
Q1 | $9.58M | Sell |
10,421
-400
| -4% | -$406K | 2.12% | 7 |
|
|
2025
Q4 | $11.6M | Sell |
10,821
-407
| -4% | -$389K | 2.52% | 7 |
|
|
2025
Q3 | $8.57M | Sell |
11,228
-331
| -3% | -$246K | 1.93% | 10 |
|
|
2025
Q2 | $9.01M | Sell |
11,559
-502
| -4% | -$390K | 2.15% | 8 |
|
|
2025
Q1 | $9.96M | Buy |
12,061
+1,007
| +9% | +$838K | 2.45% | 8 |
|
|
2024
Q4 | $8.53M | Sell |
11,054
-274
| -2% | -$227K | 2.11% | 8 |
|
|
2024
Q3 | $10M | Sell |
11,328
-827
| -7% | -$744K | 2.5% | 8 |
|
|
2024
Q2 | $11M | Sell |
12,155
-81
| -0.7% | -$64.8K | 2.96% | 5 |
|
|
2024
Q1 | $7.13M | Hold |
12,236
| – | – | 2.07% | 8 |
|
|
2023
Q4 | $7.13M | Sell |
12,236
-23
| -0.2% | -$13.4K | 2.07% | 8 |
|
|
2023
Q3 | $6.58M | Sell |
12,259
-286
| -2% | -$147K | 2.22% | 8 |
|
|
2023
Q2 | $5.88M | Buy |
12,545
+33
| +0.3% | +$13.8K | 1.96% | 8 |
|
|
2023
Q1 | $4.3M | Sell |
12,512
-622
| -5% | -$210K | 1.5% | 11 |
|
|
2022
Q4 | $4.8M | Sell |
13,134
-214
| -2% | -$75.9K | 1.69% | 10 |
|
|
2022
Q3 | $4.32M | Buy |
13,348
+23
| +0.2% | +$7.29K | 1.72% | 11 |
|
|
2022
Q2 | $4.32M | Sell |
13,325
-108
| -0.8% | -$32.4K | 1.65% | 12 |
|
|
2022
Q1 | $3.85M | Buy |
13,433
+9
| +0.1% | +$2.32K | 1.27% | 15 |
|
|
2021
Q4 | $3.71M | Sell |
13,424
-1
| -0% | -$254 | 1.26% | 13 |
|
|
2021
Q3 | $3.47M | Sell |
13,425
-307
| -2% | -$75.8K | 1.26% | 17 |
|
|
2021
Q2 | $2.74M | Sell |
13,732
-18
| -0.1% | -$3.62K | 1.06% | 18 |
|
|
2021
Q1 | $2.82M | Sell |
13,750
-17
| -0.1% | -$3.33K | 1.23% | 14 |
|
|
2020
Q4 | $2.33M | Sell |
13,767
-13
| -0.1% | -$1.94K | 1.04% | 18 |
|
|
2020
Q3 | $2.04M | Buy |
13,780
+131
| +1% | +$20.3K | 1% | 18 |
|
|
2020
Q2 | $2.24M | Buy |
13,649
+50
| +0.4% | +$7.67K | 1.33% | 14 |
|
|
2020
Q1 | $1.89M | Sell |
13,599
-4
| -0% | -$550 | 1.34% | 16 |
|
|
2019
Q4 | $1.79M | Buy |
13,603
+791
| +6% | +$91.7K | 0.91% | 25 |
|
|
2019
Q3 | $1.43M | Sell |
12,812
-4,079
| -24% | -$454K | 0.76% | 35 |
|
|
2019
Q2 | $1.87M | Buy |
16,891
+5,528
| +49% | +$651K | 0.66% | 34 |
|
|
2019
Q1 | $1.47M | Sell |
11,363
-241
| -2% | -$29.3K | 0.84% | 23 |
|
|
2018
Q4 | $1.34M | Buy |
+11,604
| New | +$1.3M | 0.84% | 25 |
|
Other funds holding LLY
Essex Savings Bank's LLY Position: Q2 2026 in Review
Essex Savings Bank reduced its Eli Lilly (LLY) stake by 0.52% in Q2 2026, selling an estimated $55.2K and leaving 10,367 shares worth $12.4M. The position accounts for 2.69% of the portfolio, ranked #4.
Essex Savings Bank first reported a position in LLY in Q4 2018 and has held it in 31 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Essex Savings Bank held 10,367 shares of Eli Lilly worth $12.4M as of Q2 2026.
- Essex Savings Bank sold 54 Eli Lilly shares in Q2 2026, an estimated $55.2K.
- Eli Lilly made up 2.69% of Essex Savings Bank's portfolio in Q2 2026, its #4 holding.
- Essex Savings Bank first reported a position in Eli Lilly in Q4 2018 and has held it in 31 quarters since.
- 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Essex Savings Bank's 13F filing for Q2 2026, filed 23 Jul 2026.